{"id":"https://openalex.org/W4288065859","doi":"https://doi.org/10.4103/ijp.ijp_129_18","title":"Sulfasalazine-induced drug rash with eosinophilia and systemic symptoms syndrome in a seronegative spondyloarthritis patient: A Case report","display_name":"Sulfasalazine-induced drug rash with eosinophilia and systemic symptoms syndrome in a seronegative spondyloarthritis patient: A Case report","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W4288065859","doi":"https://doi.org/10.4103/ijp.ijp_129_18"},"language":"en","primary_location":{"id":"doi:10.4103/ijp.ijp_129_18","doi":"https://doi.org/10.4103/ijp.ijp_129_18","is_oa":false,"landing_page_url":"https://doi.org/10.4103/ijp.ijp_129_18","pdf_url":null,"source":{"id":"https://openalex.org/S112348374","display_name":"Indian Journal of Pharmacology","issn_l":"0253-7613","issn":["0253-7613","1998-3751"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067795633","display_name":"Balakeshwa Ramaiah","orcid":"https://orcid.org/0000-0002-5332-4370","observed_orcids":["https://orcid.org/0000-0002-5332-4370"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Balakeshwa Ramaiah","raw_affiliation_strings":["Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India","Dr. Balakeshwa Ramaiah, Department of Pharmacy Practice, Karnataka College of Pharmacy, #33/2, Tirumenahalli, Hegde Nagar Main Road, Bengaluru - 560 064, Karnataka, India. E-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India","institution_ids":[]},{"raw_affiliation_string":"Dr. Balakeshwa Ramaiah, Department of Pharmacy Practice, Karnataka College of Pharmacy, #33/2, Tirumenahalli, Hegde Nagar Main Road, Bengaluru - 560 064, Karnataka, India. E-mail: [email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Naresh Sah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naresh Sah","raw_affiliation_strings":["Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072599565","display_name":"Raju Koneri","orcid":"https://orcid.org/0000-0003-0568-7131","observed_orcids":["https://orcid.org/0000-0003-0568-7131","https://orcid.org/0000-0002-0858-7403"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raju Koneri","raw_affiliation_strings":["Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5067795633"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5158,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.57430258,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"53","issue":"5","first_page":"391","last_page":"391"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulfasalazine","display_name":"sulfasalazine","score":0.9700000286102295},{"id":"https://openalex.org/keywords/seronegative-spondyloarthritis","display_name":"seronegative spondyloarthropathy","score":0.9309999942779541},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8790000081062317},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.4830000102519989},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/sulfonamides","display_name":"sulfonamides","score":0.722000002861023},{"id":"https://openalex.org/keywords/drug-safety-reporting","display_name":"drug safety reporting","score":0.5809999704360962},{"id":"https://openalex.org/keywords/inflammatory-polyarthritis","display_name":"inflammatory polyarthritis","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2779383735","wikidata":"https://www.wikidata.org/wiki/Q420035","display_name":"Sulfasalazine","level":4,"score":0.942583441734314},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9214521050453186},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7437157034873962},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.648409366607666},{"id":"https://openalex.org/C2777129736","wikidata":"https://www.wikidata.org/wiki/Q505142","display_name":"Eosinophilia","level":2,"score":0.6382259726524353},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.5831236243247986},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.4602872431278229},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.44014352560043335},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4334413409233093},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3808828592300415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3483034670352936},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3407002389431},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.33377504348754883},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.10005706548690796},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08613032102584839},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4103/ijp.ijp_129_18","doi":"https://doi.org/10.4103/ijp.ijp_129_18","is_oa":false,"landing_page_url":"https://doi.org/10.4103/ijp.ijp_129_18","pdf_url":null,"source":{"id":"https://openalex.org/S112348374","display_name":"Indian Journal of Pharmacology","issn_l":"0253-7613","issn":["0253-7613","1998-3751"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320448","host_organization_name":"Medknow","host_organization_lineage":["https://openalex.org/P4310320448","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Medknow","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Indian Journal of Pharmacology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1919335710","https://openalex.org/W2033441465","https://openalex.org/W2089773605","https://openalex.org/W2767940675"],"related_works":["https://openalex.org/W4386554009","https://openalex.org/W4213413001","https://openalex.org/W7120311789","https://openalex.org/W2033441465","https://openalex.org/W4395004488","https://openalex.org/W2895155649","https://openalex.org/W4385777330","https://openalex.org/W7162133839","https://openalex.org/W7132854533","https://openalex.org/W2570243007"],"abstract_inverted_index":{"The":[0,56,86],"objectives":[1],"were":[2],"to":[3,14,17,116,125,137,153,157],"evaluate":[4],"drug":[5,27,158],"rash":[6],"with":[7,24,35,80,146],"eosinophilia":[8],"and":[9,16,39,53,66,79,97,106,149],"systemic":[10],"symptoms":[11],"syndrome":[12],"due":[13],"sulfasalazine":[15,49,78],"carry":[18],"out":[19],"the":[20,42,81,112,131],"pharmacoeconomic":[21],"assessment":[22,100],"associated":[23,145],"this":[25,89],"adverse":[26],"reaction":[28],"(ADR).":[29],"A":[30],"37-year":[31],"woman":[32],"was":[33,47,58,73,91,104,114],"presented":[34],"rashes,":[36],"fever,":[37],"cough,":[38],"dyspnea.":[40],"In":[41],"past":[43],"3":[44],"months,":[45],"she":[46],"on":[48,60,94],"for":[50,109],"inflammatory":[51],"polyarthritis":[52],"seronegative":[54],"spondyloarthritis.":[55],"diagnosis":[57],"based":[59,93],"raised":[61],"eosinophils":[62],"count,":[63],"breathing":[64],"difficulty,":[65],"typical":[67],"pattern":[68],"of":[69,77,83,88,111,141],"rashes.":[70],"Significant":[71],"improvement":[72],"seen":[74],"after":[75],"discontinuation":[76],"initiation":[82],"parenteral":[84],"corticosteroids.":[85],"casualty":[87,99],"ADR":[90,113],"\u201cprobable\u201d":[92],"RegiSCAR,":[95],"WHO,":[96],"Naranjo":[98],"scales.":[101],"Preventability,":[102],"severity":[103],"assessed":[105],"total":[107],"cost":[108],"management":[110],"found":[115],"be":[117,138,151],"'":[118],"12,126.":[119],"Thus,":[120],"ADRs":[121,144,156],"not":[122],"only":[123],"adds":[124],"patient":[126],"sufferings":[127],"but":[128],"also":[129],"increase":[130],"economic":[132],"burden.":[133],"Health-care":[134],"providers":[135],"need":[136],"made":[139],"aware":[140],"potentially":[142],"fatal":[143],"sulfa":[147],"drugs":[148],"should":[150],"keen":[152],"report":[154],"such":[155],"safety":[159],"authorities.":[160]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-07-28T00:00:00"}